(Q38056436)

27 August 2017

title

Anti-infective properties of bacteriocins: an update (English)

1 reference

27 August 2017

1

1 reference

27 August 2017

Benoit Fernandez

2

1 reference

27 August 2017

Christophe Lacroix

series ordinal

3

1 reference

27 August 2017

Ismail Fliss

series ordinal

4

1 reference

27 August 2017

publication date

30 October 2012

1 reference

Cellular and Molecular Life Sciences

27 August 2017

published in

1 reference

27 August 2017

volume

70

1 reference

27 August 2017

issue

16

1 reference

27 August 2017

page(s)

2947-2967

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-012-1202-3

27 August 2017

exact match

0 references

cites work

Nontyphoidal salmonellosis

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

In vitro efficacy of nisin Z against Candida albicans adhesion and transition following contact with normal human gingival cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Identification of a haemolysin-like peptide with antibacterial activity using the draft genome sequence of Staphylococcus epidermidis strain A487.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

The biology, prevention, diagnosis and treatment of periodontal diseases: scientific advances in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Activity of bacteriocins synthesized by Bacillus thuringiensis against Staphylococcus aureus isolates associated to bovine mastitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Molecular and genetic characterization of a novel bacteriocin locus in Enterococcus avium isolates from infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Salivaricin D, a novel intrinsically trypsin-resistant lantibiotic from Streptococcus salivarius 5M6c isolated from a healthy infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Characterization of garvicin ML, a novel circular bacteriocin produced by Lactococcus garvieae DCC43, isolated from mallard ducks (Anas platyrhynchos).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

The ability of nisin F to control Staphylococcus aureus infection in the peritoneal cavity, as studied in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Extended Safety Data for the Oral Cavity Probiotic Streptococcus salivarius K12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Biosynthesis and mode of action of lantibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

New antibiotics from bacterial natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Bacteriocins reduce Campylobacter colonization and alter gut morphology in turkey poults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Bacteriocins: developing innate immunity for food

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Update on the development of a novel dry cow therapy using a bismuth-based intramammary teat seal in combination with the bacteriocin lacticin 3147.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Ruminococcin C, a new anti-Clostridium perfringens bacteriocin produced in the gut by the commensal bacterium Ruminococcus gnavus E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Exoproducts of the Escherichia coli strain H22 inhibiting some enteric pathogens both in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Nisin F in the treatment of respiratory tract infections caused by Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Characterization of the structural gene encoding nisin F, a new lantibiotic produced by a Lactococcus lactis subsp. lactis isolate from freshwater catfish (Clarias gariepinus).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Evaluation of Nisin F in the Treatment of Subcutaneous Skin Infections, as Monitored by Using a Bioluminescent Strain of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Ribosomally synthesized antibacterial peptides in Gram positive bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Fate and efficacy of lacticin 3147-producing Lactococcus lactis in the mammalian gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Safety study of an antimicrobial peptide lactocin 160, produced by the vaginal Lactobacillus rhamnosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

The continuing story of class IIa bacteriocins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

The bacteriocin nisin, an effective agent for the treatment of staphylococcal mastitis during lactation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Diversity of enterococcal bacteriocins and their grouping in a new classification scheme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Fate of the two-component lantibiotic lacticin 3147 in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Pharmacodynamic activity of the lantibiotic MU1140.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Inhalation of Moli1901 in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Spontaneous resistance in Lactococcus lactis IL1403 to the lantibiotic lacticin 3147.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Economic effects of bovine mastitis and mastitis management: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

BACTIBASE: a new web-accessible database for bacteriocin characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

BACTIBASE second release: a database and tool platform for bacteriocin characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Probiotics in intestinal and non-intestinal infectious diseases--clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Modification of an effector strain for replacement therapy of dental caries to enable clinical safety trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Campylobacters as zoonotic pathogens: a food production perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Effects of probiotic Lactobacillus salivarius WB21 on halitosis and oral health: an open-label pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Staphylococcal cutaneous infections: invasion, evasion and aggression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Enterocin 96, a novel class II bacteriocin produced by Enterococcus faecalis WHE 96, isolated from Munster cheese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Efficacy of the new lantibiotic NAI-107 in experimental infections induced by multidrug-resistant Gram-positive pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Clostridium difficile infection: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Macrolide antibiotics in the ribosome exit tunnel: species-specific binding and action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Characterization and structure identification of an antimicrobial peptide, hominicin, produced by Staphylococcus hominis MBBL 2-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Class II one-peptide bacteriocins target a phylogenetically defined subgroup of mannose phosphotransferase systems on sensitive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Swimming against the tide: progress and challenges in our understanding of colicin translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

A class IIa peptide from Enterococcus mundtii inhibits bacteria associated with otitis media.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

The vaginal microbiome: new information about genital tract flora using molecular based techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Isolation and purification of enterocin E-760 with broad antimicrobial activity against gram-positive and gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Microbiology and treatment of halitosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Efficacy of microcin J25 in biomatrices and in a mouse model of Salmonella infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Foodborne enteric infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Isolation and characterization of carnocyclin a, a novel circular bacteriocin produced by Carnobacterium maltaromaticum UAL307.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

The pyocins of Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Bacteriocins: mechanism of membrane insertion and pore formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

In vivo activity of mutacin B-Ny266.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Insights into the mode of action of the two-peptide lantibiotic haloduracin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Further characterization of a bacteriocin produced by Lactobacillus paracasei HL32.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Nuclease colicins and their immunity proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Bacteriocins - exploring alternatives to antibiotics in mastitis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

The Lantibiotic Lacticin 3147 Prevents Systemic Spread of Staphylococcus aureus in a Murine Infection Model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Bioengineering of a Nisin A-producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Pneumonia and Other Respiratory Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Antimicrobial activity of lacticin 3,147 against clinical Clostridium difficile strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Evaluation of antimicrobial peptide nisin as a safe vaginal contraceptive agent in rabbits: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Effect of Lactobacillus salivarius bacteriocin Abp118 on the mouse and pig intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Bacteriocins: evolution, ecology, and application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Clostridium difficile infection: new developments in epidemiology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Enterocin CRL35 inhibits Listeria monocytogenes in a murine model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Amino acid and nucleotide sequence, adjacent genes, and heterologous expression of hiracin JM79, a sec-dependent bacteriocin produced by Enterococcus hirae DCH5, isolated from Mallard ducks (Anas platyrhynchos).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Identification and characterization of lactocyclicin Q, a novel cyclic bacteriocin produced by Lactococcus sp. strain QU 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Acute otitis media-diagnosis and treatment in the era of antibiotic resistant organisms: updated clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Inhibitory activity against the fish pathogen Lactococcus garvieae produced by Lactococcus lactis TW34, a lactic acid bacterium isolated from the intestinal tract of a Patagonian fish

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Spermicidal bacteriocins: lacticin 3147 and subtilosin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Activity of pyocin S2 against Pseudomonas aeruginosa biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Pulmonary pharmacokinetics and safety of nebulized duramycin in healthy male volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Paenibacillus polymyxa purified bacteriocin to control Campylobacter jejuni in chickens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Isolation of a Lactobacillus salivarius strain and purification of its bacteriocin, which is inhibitory to Campylobacter jejuni in the chicken gastrointestinal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Spermicidal activity of the safe natural antimicrobial peptide subtilosin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Isolation of the Bacillus subtilis antimicrobial peptide subtilosin from the dairy product-derived Bacillus amyloliquefaciens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Antimicrobial Activities of Bacteriocins E 50-52 and B 602 Against Antibiotic-Resistant Strains Involved in Nosocomial Infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Isolation of Lactobacillus salivarius 1077 (NRRL B-50053) and characterization of its bacteriocin, including the antimicrobial activity spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Diverse antimicrobial killing by Enterococcus faecium E 50-52 bacteriocin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Bacteriocins to control Campylobacter spp. in poultry--A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Isolation of Bacillus circulans and Paenibacillus polymyxa strains inhibitory to Campylobacter jejuni and characterization of associated bacteriocins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Inhibitory effect of oral Lactobacillus against oral pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Do probiotics offer opportunities to manipulate the periodontal oral microbiota?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Zinc Lactate and Sapindin Act Synergistically with Lactocin 160 Against Gardnerella vaginalis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Lactocin 160, a Bacteriocin Produced by Vaginal Lactobacillus rhamnosus, Targets Cytoplasmic Membranes of the Vaginal Pathogen, Gardnerella vaginalis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Evaluating the feasibility of lantibiotics as an alternative therapy against bacterial infections in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Listeria pathogenesis and molecular virulence determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Lactococcus garvieae in fish: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Characterization of anti-Legionella activity of warnericin RK and delta-lysin I from Staphylococcus warneri

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Lantibiotics: peptides of diverse structure and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Molecular and genetic characterization of a novel nisin variant produced by Streptococcus uberis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Uberolysin: a novel cyclic bacteriocin produced by Streptococcus uberis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Therapeutic effect of nisin Z on subclinical mastitis in lactating cows

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Shotgun metaproteomics of the human distal gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

The spectrum of antimicrobial activity of the bacteriocin subtilosin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-012-1202-3

Nisin F-loaded brushite bone cement prevented the growth of Staphylococcus aureus in vivo

21 January 2018

1 reference

12 December 2020

Applications of bacteriocins in livestock

1 reference

12 December 2020

Efficacy of a teat dip containing the bacteriocin lacticin 3147 to eliminate Gram-positive pathogens associated with bovine mastitis

1 reference

12 December 2020

Nisin F, intraperitoneally injected, may have a stabilizing effect on the bacterial population in the gastro-intestinal tract, as determined in a preliminary study with mice as model

1 reference

12 December 2020

Antimycobacterial activity of bacteriocins and their complexes with liposomes

1 reference

12 December 2020

The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions

1 reference

12 December 2020

Safety assessment of ProBiora3, a probiotic mouthwash: subchronic toxicity study in rats

1 reference

12 December 2020

Colicins and microcins: the next generation antimicrobials.

1 reference

12 December 2020

Antimicrobial and safety aspects, and biotechnological potential of bacteriocinogenic enterococci isolated from mallard ducks (Anas platyrhynchos)

1 reference

12 December 2020

A new structure-based classification of gram-positive bacteriocins

1 reference

12 December 2020

Bacteriocin ST91KM, produced by Streptococcus gallolyticus subsp. macedonicus ST91KM, is a narrow-spectrum peptide active against bacteria associated with mastitis in dairy cattle

1 reference

12 December 2020

New biologically active hybrid bacteriocins constructed by combining regions from various pediocin-like bacteriocins: the C-terminal region is important for determining specificity.

1 reference

12 December 2020

The natural antimicrobial peptide subtilosin acts synergistically with glycerol monolaurate, lauric arginate, and ε-poly-L-lysine against bacterial vaginosis-associated pathogens but not human lactobacilli.

1 reference

12 December 2020

Efficacy of nisin in treatment of clinical mastitis in lactating dairy cows

1 reference

12 December 2020

Purification and characterization of two novel antimicrobial peptides Subpeptin JM4-A and Subpeptin JM4-B produced by Bacillus subtilis JM4

1 reference

12 December 2020

Bacteriocins of gram-positive bacteria

1 reference

12 December 2020

Mode of transmission of Legionella pneumophila. A critical review

1 reference

12 December 2020

The lantibiotic lacticin 3147 produced in a milk-based medium improves the efficacy of a bismuth-based teat seal in cattle deliberately infected with Staphylococcus aureus

1 reference

12 December 2020

The evolution of reduced microbial killing

1 reference

12 December 2020

Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes

1 reference

12 December 2020

Purification and partial characterization of novel bacteriocin L23 produced by Lactobacillus fermentum L23

1 reference

12 December 2020

Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon.

1 reference

12 December 2020

Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius

1 reference

12 December 2020

Genetics of bacteriocins produced by lactic acid bacteria

1 reference

12 December 2020

Preliminary assessment of safety and effectiveness in humans of ProBiora3, a probiotic mouthwash

1 reference

12 December 2020

Pumilicin 4, a novel bacteriocin with anti-MRSA and anti-VRE activity produced by newly isolated bacteria Bacillus pumilus strain WAPB4

1 reference

12 December 2020

In vivo study on the effectiveness of pediocin PA-1 and Pediococcus acidilactici UL5 at inhibiting Listeria monocytogenes

1 reference

12 December 2020

Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial

1 reference

12 December 2020

Mode of action and In Vitro susceptibility of mastitis pathogens to macedocin ST91KM and preparation of a teat seal containing the bacteriocin

1 reference

12 December 2020

Activity of staphylococcal bacteriocins against Staphylococcus aureus and Streptococcus agalactiae involved in bovine mastitis

1 reference

12 December 2020

10.1007/S00018-012-1202-3

Identifiers

DOI

1 reference

27 August 2017

1 reference